2013 Anthony 2014 nolAn · was created by Anthony Nolan’s mother, Shirley, in the hope of finding a cure for the life-threatening blood disorder her son had been born with. In 2014

Anthony nolAn

2013 2014

AnnuAl RepoRt And Accounts

2 Heathgate Place 75-87 Agincourt Road Hampstead London NW3 2NU 0303 303 0303

Anthony nolAn

2013 2014


2 Heathgate Place 75-87 Agincourt Road Hampstead London NW3 2NU 0303 303 0303

40 years of lifesaving stories

40 years ago, in 1974, something incredible was born.

A register of potential bone marrow donors was created by Anthony Nolan’s mother, Shirley, in the hope of finding a cure for the life-threatening blood disorder her son had been born with.

In 2014 Anthony’s legacy lives on. Every day we match incredible individuals willing to donate their blood stem cells to people with blood cancer who desperately need lifesaving transplants.

And, every day, wonderful stories begin when a stranger does something amazing to save the life of someone they’ve never met.

A 40th anniversary is not only a good time to celebrate what we’ve achieved: it’s also a great time to reassess the way in which we work, how we reach people, and how we can maximise the impact of our lifesaving work.

Table Of Contents

1 Statement From The Chairman And Chief Executive

TRUSTEES REPORT

5 Why We Are Here

7 How We Operate

STRATEgIC REPORT

13 The Story So Far

23 Where We Are going And How We Will get There

27 The Financial Review

31 Our Finances Independent Auditor’s Report Consolidated Statement Of Financial Activities Parent Charity Only Statement Of Financial Activities Consolidated And Charity Balance Sheets Consolidated Cash Flow Statement Financial Statements Notes To The Financial Statements

Anthony nolAn

2013 2014


England And Wales Charity Registration Number 803716

Scotland Charity Registration Number SC038827

Company Registration Number 02379280

Board of Trustees Chairman Simon Dyson MBE*

Trustees Fran Burke Lionel Cashin Professor John goldman (died 24 December 2013)Peter Harrison Ian Krieger* David Noon Dr Colin Rickard* Professor K Michael Spyer Paul Stanley* Brian Turner CBE Karin Swann (resigned 25 March 2014) * Audit Committee member

Medical Director Professor Charles Craddock

Senior Management Team

Chief Executive Henny Braund

Communications & Marketing Director Richard Davidson

Finance & Resources Director Jonathan Bell

Fundraising Director Catherine Miles

IT Director Andrew Broadbent

Operations Director Nicola Alderson

Commercial Director Timothy Fox

Bioinformatics Director Professor Steven Marsh

Scientific Director Professor J Alejandro Madrigal

Laboratory Director Dr Katy Latham

Chief Medical Officer Dr Bronwen Shaw

Auditor & Accountants Baker Tilly UK Audit LLP 25 Farringdon Street, London EC4A 4AB

Bankers Barclays Bank plc 1 Churchill Place London E14 5HP

Solicitors Bates, Wells and Braithwaite 2-6 Cannon Street London EC4M 6YH

Registered Office Royal Free Hospital Pond Street Hampstead London NW3 2Qg

Administrative Address 2 Heathgate Place 75-87 Agincourt Road Hampstead London NW3 2NU 0303 303 0303

Photography by Stephen Pennells

Cha

irm

an &

Chi

ef E

xecu

tive

St

atem

ent

January 1974 – Shirley Nolan sets up the Anthony Nolan register

‘ I believe that Anthony represented much more than the struggle to establish a bone marrow transplant programme in Britain. He represents the rights of the individual in our society, especially those of our children, and their basic human right of a chance to lead a normal, healthy life.’

Shirley Nolan

Shirley Nolan’s cause, from humble beginnings 40 years ago, grew to form an organisation that saves lives in a way few others can claim to do. We now have over 500,000 donors on our register. That’s half a million people who could save the life of someone with blood cancer.19-

74

‘ We have a long road ahead but I look to the day when no child dies like my son, waiting for a donor to save him.’

Shirley Nolan

Statement From The Chairman And Chief Executive

40 years ago this year a register of potential bone marrow donors was created by Anthony Nolan’s mother, Shirley, in the hope of finding a cure for the life-threatening blood disorder her son had been born with.

In 2014 Anthony’s legacy lives on. It has been an amazing four decades for the charity, and we are tremendously proud of what we have achieved. We have led the way with the world’s first bone marrow register; saliva testing for people joining the register; world-class research into stem cell matching; and the setting up of the UK’s first dedicated cord blood bank.

The last ten years have seen consistent and constant financial growth, and crucially, the number of donors we have identified for transplants has tripled. But we are not ones to rest on our laurels and, in the last 12 months, we have done more, broken new ground and saved even more lives, with the result that our work is more in demand than it has ever been.

We have reached many memorable milestones. In December we reached and passed 500,000 donors on our register. And in this financial year we facilitated 1,240 lifesaving transplants.

21

‘I’d like to meet him or her one day. If they write a letter to me I’d be happy to write one back, but if they don’t that’s OK. I just hope they’re getting better, I just hope that I’ve helped – that’s the most important thing.’

Victoria Rathmill

There have also been many incredible personal stories.

Victoria Rathmill became the youngest person in the world to donate her bone marrow to a stranger, at just 17 years of age. There was also the inspiring story of two-year-old gaurav Bains, who was diagnosed with the rare blood disorder, Monosomy 7 Syndrome. His family launched an appeal for donors and we saw a 1,200% increase in Asian people applying to join our bone marrow register online. Then we heard the great news in December that a matching donor had been found and gaurav was able to have a transplant.

These inspiring stories of lifesavers and the people whose lives they saved are what we, as a charity, strive to achieve. However we simply couldn’t be there for those people without the doctors, nurses and scientists we work with in hospitals, as well as our partners in the NHS and other organisations, doing incredible work to save lives.

This year the Department of Health confirmed the next stage of their funding for our ongoing partnership with NHSBT, guaranteeing a further £4 million in funding to support our work. We were also successful in a bid for the government’s Regional growth Fund scheme, gaining £1.7m that allowed us to open three new cord collection centres and a second processing shift at our bank in Nottingham.

Our first Post-Transplant Nurse Specialist will shortly begin work and we were also awarded a grant by the Wolfson Foundation towards the cost of our two new liquid handling instruments, Hamilton Robots.

We know all of our lifesaving would not be possible without our fantastic supporters who helped us raise an amazing £8.2m – and to say thank you we launched our first ever Supporter Awards.

We would also like to thank the patients who inspire our work, the selfless donors and, of course, our wonderful staff and volunteers.

Finally, we’d like to take this opportunity to remember the life of Professor John goldman, who sadly passed away last year, aged 75. As our Medical Director and later a Trustee, John was a leading figure in the global fight against blood cancer and his work transformed the lives of hundreds of thousands of patients worldwide.

John’s remarkable vision will continue to drive our work at Anthony Nolan. We will continue to endeavour to help every single person in need of a transplant find a good matching donor, have a successful transplant and then have a good quality of life. That was Shirley Nolan’s dream 40 years ago when she set up our charity, and we will not rest until it has been achieved.

Chairman, Simon Dyson, MBE

Chief Executive, Henny Braund

43

1986 – The Big Campaign

A Round Table campaign signs up 100,000 donors in six weeks. Our long relationship, which continues today, has raised millions of pounds to support Anthony Nolan’s lifesaving work and found thousands of donors.

‘Anthony Nolan is incredibly fortunate to have had such constant support from the Round Table throughout its 40 year history. Tablers have been with us every step of the way and I have no doubt that Anthony Nolan would not be here today without the Round Table.’

Simon Dyson, Chairman

40 years on, we have inspiring individuals and groups from around the country helping to sign up thousands of donors. Last year, for example, following an appeal by the family of two-year-old gaurav Bains, who was diagnosed with a rare blood disorder, we saw a 1,200% increase in Asian people applying to join our register online.

19- 86

Why

We

Are

Her

e

‘ It’s fair to say that I always feel lucky to be here. I was never supposed to live past two but luckily, after finding an unrelated donor, I did. Nowadays, thanks to the work of Anthony Nolan and improved treatments, survival of conditions like chronic granulomatous disease is far more likely.’

Simon Bostic

TRUSTEES REPORT

Why We Are Here

At Anthony Nolan we exist to help save the lives of people with blood cancer who need a blood stem cell or bone marrow transplant. We are a pioneering charity that saves the lives of people with blood cancers such as leukaemia, myeloma or lymphoma and other serious blood disorders.

For 40 years we have matched remarkable individuals willing to donate their blood stem cells to people who desperately need lifesaving transplants.

Our objectives are to:

• provide relief, treatment or cures for people with blood cancer or similar immunological deficiencies, diseases or conditions

• provide information to help people with blood cancer

• carry out research into the causes, diagnosis and treatment of blood cancer

• advance research into improving blood stem cell transplantation and to publish the useful results of such research.

Despite what we have achieved in our 40 years, we know we need to do even more. Every 20 minutes in the UK, someone is diagnosed with a blood cancer. Many people in need of a transplant die because a suitable match can’t be found in time to help them.

That is why we launched an ambitious new strategic plan, all under one vision:

To save the lives of everyone who needs a stem cell transplant

To make sure we realise our vision, we set ourselves four strategic aims:

• Find a donor for every patient who needs one

• Improve the quality of life of patients who have had a transplant

• Put customers in the transplant community at the heart of what we do

• Provide the right people, environment and funding to maximise our impact

Our vision is to help make sure every single person in need of a transplant can be found a successful match and has a good quality of life after their transplant. It’s a big goal but, as we move into the future, we are taking steps to make sure we get closer to achieving it.

How will we do this? In broad terms, we will:

• ensure patients get the best possible match, survive the transplant and have a good quality of life, post-transplant

• serve our customers in the transplant centres and hospitals, making sure we provide them with the right match for the right patient at the right time

• carry out research that helps patients in areas such as matching, tissue typing and post-transplant treatment

• harness the power of our supporters to raise funds and to spread the word about our lifesaving work

• recruit donors and support all those who go through the donation process

• work with partners on policy, research and campaigning to drive innovation and improve the lives of patients

We know these are ambitious aims. But we have already begun to achieve them.

65

1998 – The launch of our student group, Marrow

In 1998 James Kustow was inspired to organise a donor recruitment clinic at Nottingham University after his friend was diagnosed with leukaemia. Following the success of that single event, James went on to found Marrow, an award-winning medical student-run organisation that recruits students to our register.

In 2014 Marrow is now a 44-strong network of student groups who this year broke records yet again. They signed up an astonishing 11,606 potential lifesavers across 321 events and raised an amazing £117,000.19-

98H

ow W

e O

per

ate

‘ My condition is genetic so I want to be a world-leading geneticist. Then I can invent a cure that’s really easy for all people who have CgD.’

Alex Hannard

How We Operate

Organisational Structure

Anthony Nolan is a registered charity and a company limited by guarantee, not having share capital. Every member undertakes to contribute an amount not exceeding £1 to the assets of the charity in the event of the charity being wound-up during the period of their membership, or within one year thereafter. The members are the Trustees and Directors of the charity. The charity’s governing document is in the form of a memorandum and articles association dated 6 March 1989.

The overall strategic direction of the charity is determined by the Trustees, who meet formally at least four times each year. The Trustees are responsible for planning and policy-making for Anthony Nolan and, accordingly, all key decisions are referred to and taken by the Board of Trustees.

The day-to-day management of Anthony Nolan is entrusted to the Chief Executive and the senior management team, who have delegated authority from the Board to administer the affairs of the charity. The Chief Executive and senior management team are invited to the Trustees’ meetings, and provide them with regular reports on the work of Anthony Nolan.

The Trustees have taken the Charity Commission’s general guidance on public benefit (contained within the guidance publication Charities and Public Benefit) and specific guidance on public benefit (contained within the guidance publication Public Benefit and Fee-Charging) into consideration in preparing their statements on public benefit contained within this Trustees’ annual report.

Senior Management Team

Anthony Nolan’s senior management team meets on a regular basis, and departmental meetings are held throughout the year.

Employees

Policy For Disabled Persons

Anthony Nolan operates a clear policy of equal opportunity for people with disabilities, which is communicated to all staff in our staff handbook. Anthony Nolan makes a specific commitment to employing people with disabilities wherever and whenever possible. Our policies reflect our desire to treat disabled persons fairly in all aspects of recruitment and employment and we have committed ourselves to providing assistance in career progression and training. We welcome ideas for making our facilities more user-friendly for the benefit of staff with disabilities.

Employee Information

The senior management team regularly provides information to employees through the publication of a quarterly magazine distributed to staff, through all-staff briefings held twice a year, as well as through weekly emails from the Chief Executive to all staff and a variety of other communications.

Regular consultations are held with staff through Anthony Nolan’s Staff Forum, at which representatives from Human Resources are always present, to enable us to take employees’ views into account. Employee views are also sought on a variety of issues through web-based surveys

87

‘ I think when you’re diagnosed with cancer you’ve got two options: you beat it or you let it beat you. And I think what got me and Paula through the transplant was Ryan himself. He never once complained, he just got on with it.’

Stuart, Ryan’s dad

as well as Anthony Nolan’s participation in the Sunday Times 100 Best Companies survey.

Presentations by members of the commercial and finance teams to the organisation’s senior and divisional staff help to create a common awareness of the financial and economic factors affecting Anthony Nolan’s performance.

Sub-Committees

An Audit Committee, chaired by Ian Krieger, is a formal sub-committee of the Board of Trustees. The Chief Executive and the Finance & Resources Director are invited to attend the meetings.

Anthony Nolan Trading

The charity owns 100% of the issued share capital of Anthony Nolan Trading Limited (ANTL). This subsidiary plays a crucial role in fundraising on behalf of the charity and the principal activity of ANTL is to carry on the trading operations of the group with a view to raising funds. This is achieved through advertising, selling merchandise, fundraising events and exploiting intellectual and similar rights held by the parent charity.

Recruitment, Appointment, Election, Induction And Training Of Trustees

Recruitment And Appointment

Appointment to the Board of Trustees is by invitation after the needs of the charity and the range of suitable candidates are considered by the Trustees. The number of Trustees is not subject to a maximum, but must be three or greater.

Election

The Trustees retire from the Board by rotation every three years with the option of re-election. The Trustees aim to ensure that the composition of the Board contains individuals with suitable backgrounds and experience to contribute positively to the governance of Anthony Nolan.

Since the members of Anthony Nolan are the Trustees and Directors, election and re-election is determined by the current Board in all cases.

Induction And Training

The work of Anthony Nolan involves continuously advancing scientific and medical processes of stem cell transplants. To keep Trustees aware of the charity’s operations on both a national and international level, sessions are arranged to update them on facets of Anthony Nolan’s work, either during Trustees’ meetings or away days. Presentations by outside advisers relating to specific governance issues are organised as appropriate. The induction of a new Trustee is tailored to the individual concerned. It does, however, always include the provision of key documents and information relating to Anthony Nolan, a guided tour of the charity’s operations, an introduction to key staff, and an outline the duties and responsibilities of being a trustee and director.

Declaration Of Interests

Each financial year, all Trustees complete a Declaration of Interests form and new Trustees complete a Fit & Proper Person Declaration, as recommended by HMRC. The Declaration of Interests registers are included in the year end examination by our auditors.

109

This year we were successful in a bid for the government’s Regional growth Fund scheme, allowing us to open three new cord collection centres, two in Nottingham and one in Manchester, and add a second processing shift at our bank in Nottingham.

Professional Indemnity Insurance

The charity has taken out an insurance policy that provides professional indemnity insurance cover for the Trustees. The cost of this insurance for the period was £1,421 (2011/13 £2,166).

Risk And Corporate governance Matters

The Trustees have made an assessment of the risks to which Anthony Nolan is exposed, especially those related to business, operations and finance. They have put in place a review and reporting procedure to manage and reduce those identified risks. The key risks faced by Anthony Nolan include income continuity (which is dependent in part on NHS policy); any changes in clinical practice which adversely affect the place of unrelated donors in transplant activity and cash flow, particularly from NHS hospital trusts.

Procedures are in place to review risks on a regular basis. The actions that might need to be taken have also been considered, and are monitored and formally reassessed by the Trustees annually.

Trustees’ And Directors’ Responsibilities In The Preparation Of Financial Statements

The Trustees (who are also the directors of Anthony Nolan for the purposes of company law) are responsible for preparing the Trustees’ annual report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom generally Accepted Accounting Practice). Company law requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and the group as at the balance sheet date, and of the incoming resources and application of resources, including the income and expenditure for the charitable group, for that period.

In preparing those financial statements, the Trustees are required to:

• select suitable accounting policies and then apply them consistently

• observe the methods and principles in the Charities SORP

• make judgements and estimates that are reasonable and prudent

• state whether the applicable UK Accounting Standards have been followed subject to any material departures disclosed and explained in the financial statements; and

• prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in business.

The Trustees are responsible for keeping proper accounting records, which disclose with reasonable accuracy at any time the financial position of the charitable group, and enable them to ensure that the financial statements comply with the requirements of The Companies Act 2006, The Charities Act 2011, The Charities and Investment (Scotland) Act 2005 and The Charities Accounts (Scotland) Regulations 2006. They are also responsible for safeguarding the assets of the charitable company, and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. The Trustees are responsible for the maintenance and integrity of the corporate and financial information on the charitable company’s website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

1211

2000 – The 2,500th person is provided with a lifesaving transplant

The year 2000 saw Anthony Nolan reach many milestones. We provided our 2,500th person with a lifesaving transplant; our income was more than £10 million for the first time, and Shirley Nolan was awarded an OBE.

14 years later and we continue to see constant and increased growth, both financially and in the number of transplants we provide. In 2014 we provided 1,240 transplants – that’s over 12,000 transplants since 1974 – and our work is more vital and in demand than ever.20-

00 The

Sto

ry S

o F

ar

This year we recruited 49,241 new potential donors. This meant we reached and passed the milestone of 500,000 donors on our register. That’s half a million people who could save the life of someone with blood cancer.

STRATEgIC REPORT

The Story So Far

When Shirley Nolan set up a register of potential bone marrow donors, she had a dream that every single person in need of a transplant would be able to find a successful match and have a good quality of life after their transplant.

Every year we’re getting closer to achieving that. In the last 12 months, through innovative and pioneering work – and the passion and dedication of our staff, supporters and volunteers – we have made great strides in achieving the four aims which we set out two years ago.

1413

tabled a Ten Minute Rule Bill calling for compulsory education for 16-18-year-olds on blood, organ and bone marrow donation. Seema also tabled an Early Day Motion, which 67 MPs signed, also calling for compulsory education for 16-18 year olds on blood, organ and bone marrow donation.

• We worked with the late Paul goggins MP to raise awareness of the need for a cord blood collection centre in Manchester. Paul helped establish a relationship with Central Manchester University Hospitals Trust, which led to the set up of a cord blood collection centre.

• Our ‘Reach the Six’ campaign, which focused on the 6% of the UK population who are Asian and urging them to join our register, won the Social and Charitable Campaign Award at the Asian Media Awards. The campaign saw 4,964 Asian donors join our register.

• At Leicester Royal Infirmary and Leicester general Hospital baby Alexander’s cord blood was the 5,000th to be collected in Leicester since the cord collection centres opened in October 2010.

• Through our pioneering education scheme, Register and Be a Lifesaver, we spoke to 33,833 young people aged 16–18 at 473 presentations about the life-changing difference they can make by donating their stem cells.

Aim One

Find A Donor For Every Patient Who Needs One

Right now, almost 1,800 people in the UK – 37,000 worldwide – are waiting for that vital match.

Over the past 12 months, we have worked hard to change that statistic and we’re making matches right around the world:

• We have helped facilitate 1,240 lifesaving transplants.

• We ran 1,796 new searches for UK patients, an 8% increase on the previous year. The number of Confirmatory Typing requests for UK patients from Anthony Nolan donors was 1,746, a 13% increase on the previous year. We shipped 1,041 during this period, a 21% increase on the previous year.

• We recruited 49,241 new potential donors. This meant we reached and passed the milestone of 500,000 donors on our register. That’s half a million people who could save the life of someone with blood cancer. People signed up in huge numbers online and at each of the 528 events that took place.

• October 2013 saw the first anniversary of our change in joining policy to recruit those between the ages of 16 and 30. During the last financial year, 2,940 16-year-olds and 3,962 17-year-olds joined our register. Importantly, the change in joining policy change has reduced the average age of a new donor to the register from 29 to 21. Research has shown that younger donors offer patients the best chance of life, and this makes sure that more donors than ever in the ideal age range are available to hospitals.

• Following the change to our joining policy, our youngest ever donor was found. Victoria Rathmill was only 17 but entered the record books as the youngest unrelated donor to donate lifesaving stem cells.

• Following an appeal by the family of two-year-old gaurav Bains from Birmingham, who was diagnosed with the rare blood disorder Monosomy 7 syndrome in July 2013, we saw a 1,200% increase in Asian people applying to join our register online. And in December we heard the great news that he had found a match and had a transplant.

• Marrow, our 44-strong network of student groups, broke records yet again, signing up an astonishing 11,606 potential lifesavers across 321 events and raising an amazing £117,000.

• Following an appeal by the family of Charlie Craig from Cookstown, a two-year-old battling leukaemia, the number of people from Northern Ireland signing up to our bone marrow register increased by over 2,000%.

• The Department of Health guaranteed a further £2m in funding to support our cord blood programmes and adult donor recruitment.

• We were successful in a bid for the government’s Regional growth Fund scheme, gaining £1.7m to be invested over 18 months, allowing us to open three new cord collection centres - two in Nottingham and one in Manchester - and add a second processing shift at our bank in Nottingham.

• The Policy and Public Affairs team also raised the profile of the R&Be programme among MPs. We did this with Seema Malhotra MP, who

1615

Aim Two

Improve The Quality Of Life Of Patients Who Have Had A Transplant

We know that unfortunately around 50% of patients who have had a transplant die in the short-term: so we need to focus on improving the quality of life of all of our patients before, during and after a transplant. We have done a lot of work in this area including developing our support for, and engagement with, patients. This work has been well-received by patients, their families and transplant centres and we are keen to develop it.

• We have secured funding for one Anthony Nolan Nurse Specialist for three years (with plans for two more). They will work in transplant centres and be dedicated to improving the experience of transplant patients, particularly life after transplant.

• There has been greater alignment of the UK Registries (Anthony Nolan, NHS Blood and Transplant, Welsh Bone Marrow Donor Registry) from 1 September 2013, providing UK transplant centres with a single point of contact for the facilitation and provision of donors. Delete Blood Cancer UK also recruits potential donors to the Anthony Nolan and NHS Stem Cell Registry.

• The patient experience team launched the Day Zero cards for adults and children. Every person who receives a transplant will get this card on the day they receive their cells from an unrelated donor. The card celebrates day zero - or their ‘second birthday’ - and lets them know about Anthony Nolan, how we can help and the support we can offer.

• A person’s tissue type is defined by the characteristics of six genes, collectively known as the human leukocyte antigen (HLA) genes. These HLA genes that define our tissue type are very variable, but a successful stem cell transplant all depends on finding the right HLA match. This year we increased our Patient/Donor Panel, adding over 200 pairs to the human leukocyte antigen (HLA) database and sample repository.

• We have also increased the number of HLA (1,743) and Killer cell Immunoglobulin-like Receptors (KIR) (62) sequences submitted to the IMgT /HLA and IPD-KIR Databases meaning there is a greater chance we will find lifesaving matches.

• Visits to all transplant centres started in 2013 and will continue in 2014, allowing us to cement existing relationships and develop a better informed understanding of bone marrow transplants and the teams that deliver the clinical services.

• We’ve worked with over 60 patients and families who have directly influenced our work. One of the highlights of this was working with 17 parents from all over the UK to write ‘A Parent’s guide to the Transplant Journey’ – the only support of its kind in the UK. The book will be shared with paediatric transplant centres, helping them to support parents at this difficult time. This initiative is a direct result of feedback received via our recently established parent panel.

• We created our patient and family Facebook page which now has nearly 500 followers.

• Our animation about having a transplant has been viewed over 1,000 times in three months on YouTube, and we have distributed over 500 copies of the written guide in that time.

• We launched an online Transplant Community for people to share their experiences with others. We have over 150 users signed up, with nearly 3,000 page views in three months.

• The Policy and Public Affairs team launched the ‘A Roadmap for Recovery’ campaign, which calls for an end to the postcode lottery currently seen in post-transplant care. We worked with 2020health, a think tank, to research the report that informs the campaign. The report made 13 recommendations, which would ensure all post-transplant patients receive equal access to a comprehensive service to manage the physical and mental health complications they could experience after a transplant. We took the campaign to the political party conferences.

• We were invited to become a member of the Clinical Reference group on Blood and Marrow Transplantations - the formal advisory group to NHS England on priorities to improve health and care related to bone marrow transplant.

1817

Aim Three

Put Our Customers – Transplant Centres, Clinicians – At The Heart Of What We Do.

We know that in order to provide the best possible service for hospitals and their patients, we must understand their needs and ensure that they are met.

And here is how we have been making sure we provide a first-class service:

• The first Anthony Nolan Clinical Retreat was held in September 2013 and brought together 25 of the UK’s leading bone marrow transplant clinicians. We had a hugely positive response to the event’s agenda and format which allowed us to deliver a successful meeting with a further one planned for 2014.

• We were awarded £260,000 towards our two new liquid handling instruments, Hamilton Robots from the garfield Weston Foundation and the Wolfson Foundation.

• Staff from our Laboratories, Research and Operations divisions attended the annual conference of the European Federation for Immunogenetics (EFI) in Maastricht. Prof Steve Marsh and Dr Katy Latham were invited to attend a Key Opinion Leaders Workshop on Next generation Sequencing; James Robinson was an invited speaker at a masterclass session on HLA Data Resources and Dr Esteban Arrieta presented two of his scientific posters.

• The World Marrow Donor Association (WMDA) conducted its first full on-site visit of Anthony Nolan and we were awarded full WMDA accreditation. Prior to this we were a WMDA qualified registry, but this full accreditation gives us greater international recognition and assures our external customers that we follow robust practices and meet recognised standards.

• It was announced that over 9,000 HLA alleles have been identified in individuals from all over the world. Many have only been reported in single individuals and most likely are rare alleles. Thanks to our work with the National Marrow Donor Program, the latest version of the Common and Well-Documented (CWD) alleles catalogue is now available to download. It allows scientists performing tissue typing at medium resolution to understand which alleles are likely to be present in an individual and so avoid the time consuming and costly process of excluding rare alleles.

• We have published papers in some of the most prestigious scientific journals in the world, helping to improve the outcome of bone marrow transplantation. Since 2012, our research scientists have published 56 papers in 17 journals.

• Dr Robert Lown and Dr Bronwen Shaw’s paper, ‘Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision’, received the highest number of citations of all papers published in that year.

2019

• We launched a partnership with Trinity Mirror which began with the publication in The Mirror of the story of Simon Bostic, who had the first ever bone marrow transplant from an unrelated donor. The collaboration, which links with our 40th anniversary year, will see content run in the Mirror and across a number of its regional titles, as well as engaging staff and readers to raise vital funds.

Aim Four

Provide The Right People, Environment And Funding To Maximise Our Impact.

We know that to save as many lives as possible, we must have the best staff, the right environment and the necessary resources.

And we have been working hard to make these happen:

• Fundraising income has continued to grow. Our gross fundraising income reached £8.4m, from £10m in the previous 18 month period. Net income from fundraising reached £2.8m.

• We increased our pool of regular givers to over 32,000, donating vital, consistent funds which enable us to grow our work and plan for the future.

• Over 1,500 people ran, cycled, trekked or parachuted for us, raising over £1.1m in the process.

• As official charity of the 2014 Virgin Money London Marathon we successfully recruited a team of over 500 runners, over 70% of whom had a personal link to Anthony Nolan.

• Our partnership with Virgin Money beat all targets to raise over £144,000.

• Over 1,200 individuals and groups in the community raised over £1m by doing street collections, cake sales at work, holding quiz nights and being sponsored to do the things they love.

• The family and friends of Lucas Ruddy, a three-year-old from London who received a successful transplant via Anthony Nolan, raised over £123,000 by cycling from Land’s End to John O’groats.

• There are now 45 volunteer couriers – including eight new volunteers recruited since last year. In 2013 there were 885 courier trips, 839 of which were covered by volunteer couriers.

• Over 1,000 volunteers have worked with our Register Development team through the year to recruit donors at events and to deliver Register and Be a Lifesaver presentations.

• We have seven active London donor visitors (five of whom are also couriers) and one active Sheffield visitor, with additional volunteers currently being recruited. We started using volunteer donor visitors in June 2013 and since August an average of 60% of donor visits have been carried out by volunteers, saving the time of office staff – and in January/February 2014 this increased to over 90% of visits covered by volunteers.

• We created a new Commercial division and developed the first Anthony Nolan commercial strategy. We established commercial relationships with partners such as The National Marrow Donor Program, NHSBT and Delete Blood Cancer UK (DKMS). We implemented business to business customer relationship software and developed our UK and international market intelligence.

• We were ranked number 89 in the Sunday Times “Best Not-for-Profit Organisation to work for” survey.

2221

2008 – The UK’s first dedicated cord blood bank is set up

We set up the UK’s first dedicated cord blood bank. This allows mothers to safely donate the blood from their umbilical cord and placenta after they give birth. Cord blood is rich in stem cells, which we use for lifesaving transplants.

‘ I almost wasn’t aware of the cord donation – it was all done in the room, calmly, quietly and with no fuss. I was busy getting to know my gorgeous son Toby.’

Catriona Finlayson, Toby’s Mother

In 2014 Leicester Royal Infirmary and Leicester general Hospital celebrated their 5,000th cord blood collection. Baby Alexander’s cord blood was the 5,000th cord blood to be collected in Leicester since the cord collection centres opened in October 2010.

20- 08 W

here

We

Are

go

ing

And

H

ow W

e W

ill g

et T

here

‘Right from the offset you’re mentally and physically drained so you’re limited in what you can do. But I’m a “go get ‘em” kind of person and I couldn’t sit on my backside for very long. I found myself walking and running as soon as I possibly could.’

Johnny Pearson

Where We Are going And How We Will get There

Here’s To The Next 40 Years

Pioneering spirit is something that has always marked Anthony Nolan out. And, though our 40th anniversary is a good time to reflect on what we have achieved, this same spirit will continue to be at the heart of our work as we push forward to do even more.

We have achieved some incredible things and made great strides to ensure we are closer than we ever have been to realising our goal of saving the lives of everyone who needs a stem cell transplant. We know there is still a long way to go, but we are sure the next 40 years will be even more successful.

Of course, with so much happening beyond our walls, there will be challenges. The science behind transplants; the international market for stem cells and government investment in stem cell transplantation are just some of the areas which have seen dramatic change. In order to keep achieving more and more each year, we must change with them. And we are confident in our plans for the future.

2423

Our Work And Our Staff

We also need to recruit and develop great staff and ensure that we have the best management information to support our decision-making. To help us do this we have looked to the future by launching our organisational values – Passionate, Patient-Focused, Accountable, Innovative and Improving Everyday – which will run through all the work we do and will be embodied by every member of staff.

These are the tools we will use to succeed in our ambitions. By focusing on our strengths we will build a sustainable organisation, which can continue to save lives for at least another 40 years.

‘ My football club, Crystal Palace, was the one place I found I could come and forget about my cancer. For 90 whole minutes, my focus was here.’

Chris Lewis

Raising Our game: More Transplants, More Lives Saved And Improved Support

We are now two years into our three year plan so we need to start preparing for a new three-year strategy. We have identified 12 priorities for the next year to enable us to deliver our goals.

Our current strategy is to focus on providing the best quality donors as we know that this will have the best outcomes for blood cancer patients. However, to be able to afford this in the long term we must find cheaper ways of providing this quality and amend our operating model to capitalise on commercial opportunities.

Third generation Sequencing

We know that others in our field have introduced – or have plans to introduce – next generation sequencing, enabling faster, cheaper typing on a bigger scale than previously possible. Our plan is to leapfrog them and move to the stage beyond this: third generation sequencing. Third generation sequencing means typing at the highest possible level of resolution – and doing so faster and at lower cost than we do now. We believe it will provide us with a vital competitive advantage.

We have also recently restructured our register development and donor recruitment teams which will mean that we are recruiting more, and better, potential donors.

Through the introduction of third generation sequencing and better recruitment, alongside investment in our IT infrastructure, we will be able to facilitate more transplants than ever before (our target is 1,450 in the coming year compared to around 1,240 in 2013/14).

Financially we aim to grow again next year: in 2014/15 the Fundraising team will grow income to over £5.5m net, double the net income of the 2008/09 financial period.

We have also made huge strides in our supporter development work over the last few years but we still have some way to go to make sure that our supporters understand the many ways – whether that’s fundraising, campaigning, volunteering or another way – they can get involved with us to save lives.

2625

2012The World’s Youngest Donor

In 2012 the world’s millionth stem cell transplant took place – something that was unimaginable when Shirley started her campaign. The same year, we became the first register in the world to start recruiting 16-year-olds.

It was Victoria Rathmill who, in 2013, became the world’s youngest ever stem cell donor aged just 17.

‘ It was an immediate decision. I had the opportunity to save someone’s life, I didn’t have to think about it. I wasn’t expecting it, and I was a little scared but I was excited for what it meant.’

Victoria Rathmill20- 12 Th

e F

inan

cial

Rev

iew

‘I want to be able to travel and get out there and do things, just as I would have done before the diagnosis. And I’m sure that will happen. I’m half-way there now and I feel good’.

Jim Whittall

The Financial Review

During the previous reporting period, the Trustees decided to change the year-end to March from September to align with suppliers and customers and last year we produced financial statements covering a period of 18 months. The current set of financial statements covers a period of 12 months to March 2014 and all financial comparisons are between the most recent period of 12 months and the previous period of 18 months.

During the past 12 months Anthony Nolan’s income reached £45m (from £58m in the previous 18-month period, or £39m on an annualised basis). The main reason for the underlying increase is that a greater number of transplants being carried out both worldwide and in the UK has increased demand for stem cells from unrelated donors. In the past 12 months we helped facilitate 1,240 lifesaving transplants. Income from the provision of donors exceeded £35m (from £47m in the previous 18-month period, or £31m on an annualised basis), representing underlying growth of 14%.

Many donors continue to be drawn from the world’s largest registries – in germany and the USA – and Anthony Nolan has added over 49,000 new potential donors to our register during the past 12 months to help meet growing demand domestically. Meanwhile, greater alignment of the UK registers (Anthony Nolan, NHS Blood and Transplant, Welsh Bone Marrow Donor Registry) from September 2013 now provides UK transplant centres with a single point of contact for the facilitation of the provision of donors.

Fundraising income has continued to grow. Total income from fundraising exceeded £8.2m compared to £10m in the previous 18-month period. We extended our investment in individual giving and now have over 32,000 supporters providing regular and predictable income. This investment means that net voluntary income was £2.8m compared to £4.3m in the previous period, or £2.9m on an annualised basis.

Our cost base continues to benefit from improvements in procurement and the periodic review of major costs. Donor provision costs were £34m (compared to £43m in the previous 18-month period, or £29m on an annualised basis). This underlying increase largely reflects the higher volume of transplant activity. We have also expanded and accelerated our cord collection activity which has been enabled by the Department of Health, the Regional growth Fund and the investment of our own resources. During the past 12 months we collected our 5,000th cord, which will again contribute to meeting the demand for stem cells.

Anthony Nolan’s other main charitable activities – education and awareness and research – have also increased. We spent £4.2m on these two areas in the last 12 months compared to £5.2m in the previous 18-month period, or £3.4m on an annualised basis. This reflects our stronger support for patients and the start of a three-year project on T-cell research funded by the European Union.

2827

‘ I will never forget Professor goldman agreeing to let me have kids before the transplant. I thank god every day - not that I am here, but that I fought and fought to have these boys.’

Fran Burke

Our governance costs have remained broadly unchanged (£267,000 compared to £431,000 in the previous 18-month period, or £290,000 on an annualised basis), though are likely to increase in the year ahead when we plan to refresh our strategy. Our support costs, which help all of our work, have remained steady at 12% of income, reflecting our concern to control costs as we grow. We have continued to invest in improving our core IT systems to improve access to our register and reduce the time taken to search for potential donors. This complex work is expected to be completed during the 2014/15 financial year.

Cash flow is an important part of our financial management and planning. growing organisations often experience a growth in debtors and Anthony Nolan is no exception. Nevertheless, cash levels during the period have fallen only slightly, from £5.4m to £4.6m. Changes in the practice of some hospitals has made the process of settling payments more challenging but we continue to work closely with transplant centres and overseas registers to ensure that the payment process can be as smooth as possible.

In the year ahead we will invest in the introduction of third generation sequencing and our IT infrastructure which will mean being able to type to the highest possible level of resolution – and do so faster and at lower unit cost than we do now. This, together with changes to our register development and donor recruitment teams, will help us to facilitate more transplants than ever before.

Reserves Policy

Anthony Nolan’s policy with regard to reserves is to make suitable investment in the on-going development of the charity, while maintaining adequate funds to deal with current and medium-term needs and having the necessary provision to deal with unforeseen circumstances. Free reserves at the year-end, excluding fixed assets, designated funds and restricted funds, amounted to £3.3m compared to £4.0m in the previous year.

The Trustees have determined that the optimal level for free reserves is £6m and that in the medium term free reserves should be managed to reach this level to deal with the following:

• Requirements for a reasonable level of working capital, taking into account our growth.

• Period of time required to downsize the charity operations if necessary to respond to any downturn in income streams or reduced demand for donors.

• Period of time to re-establish income streams.

The Trustees have plans in place to deliver surpluses over the next few years to reach the desired level of reserves. The appropriate level of reserves of the charity will continue to be reviewed regularly.

Auditor

Baker Tilly UK Audit LLP has indicated its willingness to continue in office.

Statement As To Disclosure Of Information To Auditor

The Trustees who were in office on the date of approval of these financial statements have confirmed as far as they are aware, that there is no relevant audit information of which the auditor is unaware. Each of the Trustees have confirmed that they have taken all the steps that they ought to have taken as Trustees in order to make themselves aware of any relevant audit information and to establish that it has been communicated to the auditor.

Funds Held As Custodian

Although the charity maintains restricted funds to deal with incoming resources that are earmarked for a particular purpose by donors, sponsors, and other funds, Anthony Nolan does not currently hold, and the Trustees do not intend that it will in the future hold, any funds as custodian for any third party.

The Trustees’ Annual Report is approved by order of the Board of Trustees and the Strategic Report (included therein) is approved by the Board of Trustees in their capacity as the directors at a meeting on 3 July 2014 and signed on their behalf by:

Chairman, Simon Dyson, MBE Date 3/7/14

3029

2014-Today, our register has more than 500,000 potential donors on it

As we celebrate 40 fantastic years our work is as in demand as it ever was, and changes lives every day.

Here’s to the next 40 years.20- 14O

ur F

inan

ces

Opinion On Other Matter Prescribed By The Companies Act 2006

In our opinion the information given in the Strategic Report and the Trustees’ Annual Report for the financial year for which the financial statements are prepared is consistent with the financial statements.

Matters On Which We Are Required To Report By Exception

We have nothing to report in respect of the following matters where the Companies Act 2006, the Charities Act 2011 and the Charities Accounts (Scotland) Regulations 2006 (as amended) requires us to report to you if, in our opinion:

• the parent charitable company has not kept sufficient, proper and adequate accounting records, or returns adequate for our audit have not been received from branches not visited by us; or

• the parent charitable company financial statements are not in agreement with the accounting records and returns; or

• certain disclosures of trustees’ remuneration specified by law are not made; or

• we have not received all the information and explanations we require for our audit.

2014

Nicholas Sladden FCA DChA (Senior Statutory Auditor) For and on behalf of BAKER TILLY UK AUDIT LLP, Statutory Auditor Chartered Accountants 25 Farringdon Street London EC4A 4AB

BAKER TILLY UK AUDIT LLP is eligible to act as an auditor in terms of section 1212 of the Companies Act 2006.

‘ I worked out what my coping mechanisms were and, for me, it was about accepting what was in my control and what wasn’t. I found myself watching grand Designs and I was fascinated – plus it became an evening ritual that I could control. As soon as I was in recovery, I started looking for houses to renovate.’

Paul Golding

Independent Auditor’s Report To The Trustees And Members Of Anthony Nolan

We have audited the group and parent charitable company’s financial statements of Anthony Nolan (“the financial statements”) for the year ended 31 March 2014 on pages 33 to 60. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom generally Accepted Accounting Practice).

This report is made exclusively to the members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006, and to the charitable company’s trustees, as a body, in accordance with section 44(1)(c) of the Charities and Trustee Investment (Scotland) Act 2005 and regulation 10 of the Charities Accounts (Scotland) Regulations 2006 (as amended) and the Charities Act 2011. Our audit work has been undertaken so that we might state to the members and the charitable company’s trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company, its members as a body, and its trustees as a body, for our audit work, for this report, or for the opinions we have formed.

Respective Responsibilities Of Trustees And Auditor

As explained more fully in the Statement of Trustees’ responsibilities set out on page 22 the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view.

We have been appointed auditors under section 44(1)(c) of the Charities and Trustee Investment (Scotland) Act 2005, section 151 of the Charities Act 2011 and under the Companies Act 2006 and report in accordance with regulations made under those Acts.

Our responsibility is to audit and express an opinion on the financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board’s (APB’s) Ethical Standards for Auditors.

Scope Of The Audit Of The Financial Statements

A description of the scope of an audit of financial statements is provided on the Financial Reporting Council’s website at www.frc.org.uk/auditscopeukprivate

Opinion On Financial Statements

In our opinion the financial statements:

- give a true and fair view of the state of the group’s and the parent charitable company’s affairs as at 31 March 2014; and of the group’s and the parent charitable company’s incoming resources and application of resources, including their income and expenditure, for the year then ended;

- have been properly prepared in accordance with United Kingdom generally Accepted Accounting Practice; and

- have been prepared in accordance with the Companies Act 2006, the Charities Act 2011, the Charities and Trustee Investment (Scotland) Act 2005 and regulations 6 and 8 of the Charities Accounts (Scotland) Regulations 2006 (as amended).

3231

The above results are derived from the group’s continuing activities. No separate Statement of Total Recognised gains and Losses has been presented as all such gains and losses are included in the Statement of Financial Activities.

Anthony Nolan & Subsidiary Undertaking

pARent cHARItY onlY stAteMent oF FInAncIAl ActIVItIes

(including Parent Charity Only Income & Expenditure Account) for the year ended 31 March 2014

Notes Unrestricted Funds 12 months

£’000

Restricted Funds 12 months

£’000

TOTAL 2014 12 months

£’000


£’000

INCOMING RESOURCES

Incoming resources from generated funds

Voluntary income 1 6,575 1,288 7,863 9,275

Investment income 3 225 - 225 274

Incoming resources from charitable activities

Donor provision 4 35,633 - 35,633 47,006

Research 5 73 458 531 428

Other incoming resources 6 112 - 112 502

TOTAL INCOMING RESOURCES 42,618 1,746 44,364 57,485

RESOURCES EXPENDED

Costs of generating funds

Cost of generating voluntary income 7 5,752 - 5,752 5,792

Charitable activities

Donor provision 7 32,956 1,045 34,001 43,029

Education and awareness 7 2,074 5 2,079 2,544

Research 7 1,763 367 2,130 2,609

Governance costs 7 267 - 267 431

TOTAL RESOURCES EXPENDED 42,812 1,417 44,229 54,405

NET (OUTGOING)/INCOMING RESOURCES BEFORE TRANSFERS (194) 329 135 3,080

TRANSFERS (gross transfers between funds) 19 298 (298) - -

NET INCOMING RESOURCES BEFORE OTHER RECOGNISED GAINS AND LOSSES 104 31 135 3,080

Losses on investments 12 (6) - (6) (7)

NET MOVEMENTS IN FUNDS 98 31 129 3,073

RECONCILIATION OF FUNDS Total funds brought forward 8,200 332 8,532 5,459

TOTAL FUNDS CARRIED FORWARD 19-20 8,298 363 8,661 8,532

Notes Unrestricted Funds 12 months

£’000


£’000


£’000


£’000

INCOMING RESOURCES

Incoming resources from generated funds

Voluntary income 1 6,575 1,288 7,863 9,275

Activities for generating funds;

Commercial trading operation 2 510 - 510 766

Investment income 3 103 - 103 148

Incoming resources from charitable activities

Donor provision 4 35,633 - 35,633 47,006

Research 5 73 458 531 428

Other incoming resources 6 48 - 48 431

TOTAL INCOMING RESOURCES 42,942 1,746 44,688 58,054

RESOURCES EXPENDED


Cost of generating voluntary income 7 5,752 - 5,752 5,792

Trading operations

Cost of goods sold and other costs 2, 7 324 - 324 513


Donor provision 7 32,956 1,045 34,001 43,029

Education and awareness 7 2,074 5 2,079 2,544

Research 7 1,763 367 2,130 2,609

Governance costs 7 267 - 267 431

TOTAL RESOURCES EXPENDED 43,136 1,417 44,553 54,918

NET (OUTGOING)/INCOMING RESOURCES BEFORE TRANSFERS (194) 329 135 3,136

TRANSFERS (gross transfers between funds) 19 298 (298) - -

NET INCOMING RESOURCES BEFORE OTHER RECOGNISED GAINS AND LOSSES 104 31 135 3,136

Losses on investments 12 (6) - (6) (7)

NET MOVEMENTS IN FUNDS 98 31 129 3,129

RECONCILIATION OF FUNDS

Total funds brought forward 8,260 332 8,592 5,463

TOTAL FUNDS CARRIED FORWARD 19-20 8,358 363 8,721 8,592


consolIdAted stAteMent oF FInAncIAl ActIVItIes

(Including Consolidated Income and Expenditure Account) for the year ended 31 March 2014

The above results are derived from the group’s continuing activities. No separate Statement of Total Recognised gains and Losses has been presented as all such gains and losses are included in the Statement of Financial Activities.

3433


consolIdAted & cHARItY cAsH FloW stAteMents For the year ended 31 March 2014

Notes group 2014 £’000

group 2013 £’000

Charity 2014 £’000

Charity 2013 £’000

NET CASH INFLOW FROM OPERATING ACTIVITIES

Net incoming resources & net income for the year, & net movement in funds 129 3,136 129 3,080

Depreciation 633 673 633 673

Investment income receivable (103) (148) (225) (274)

Taxation - (66) - -

Decrease in quoted investments 6 - 6 -

Increase in stocks (6) (111) (6) (111)

Increase in debtors (1,606) (3,067) (1,626) (2,752)

Increase in creditors 1,500 3,289 1,563 3,309

553 3,706 474 3,925

RETURNS ON INVESTMENT AND SERVICING OF FINANCE

Investment income received 103 148 225 274

CAPITAL EXPENDITURE

Payments to acquire tangible fixed assets (1,382) (1,504) (1,382) (1,504)

FINANCING

Capital element of the finance lease, total payments (43) (43) (43) (43)

(DECREASE)/INCREASE IN CASH 21, 22 (769) 2,307 (726) 2,652


consolIdAted & cHARItY BAlAnce sHeets

As at 31 March 2014

Company number: 02379280 Charity number: 803716 Charity number (Scotland): SCO38827

Notes group 2014 £’000

group 2013 £’000

Charity 2014 £’000

Charity 2013 £’000

FIXED ASSETS

Tangible assets 11 3,925 3,176 3,925 3,176

Investments 12 - 6 - 6

3,925 3,182 3,925 3,182

CURRENT ASSETS

Stocks 13 485 479 485 479

Debtors 14 10,108 8,502 10,122 8,496

Cash at bank and in hand 21,22 4,607 5,376 4,499 5,225

15,200 14,357 15,106 14,200

LIABILITIES

Creditors: Amounts falling due within one year 15 10,060 8,560 10,026 8,463

NET CURRENT ASSETS 5,140 5,797 5,080 5,737

TOTAL ASSETS LESS CURRENT LIABILITIES 9,065 8,979 9,005 8,919

Creditors: Amounts falling due after more than one year 17 28 71 28 71

Provisions for liabilities and charges 18 316 316 316 316

NET ASSETS 8,721 8,592 8,661 8,532

THE FUNDS OF THE GROUP & THE CHARITY

Restricted income funds 19 363 332 363 332

Unrestricted income funds

general Fund 19 6,858 6,770 6,798 6,710

Designated funds 19 1,500 1,500 1,500 1,500

Investment revaluation reserve - (10) - (10)

TOTAL GROUP & CHARITY FUNDS 19,20 8,721 8,592 8,661 8,532

The financial statements on pages 33 to 60 were approved by the trustees and authorised for issue on 3 July 2014 and are signed on their behalf by

Trustee I.S. Krieger

Chairman Simon Dyson, MBE

3635

‘ I choreographed a piece about my fight with leukaemia; how even though it closes in around you, you can push it away. I have shown it to a lot of people and it’s been really well received. It’s so important to me.’

Katy Burnett


FInAncIAl stAteMents For the period ended 31 March 2014

Accounting Policies

Basis Of Accounting

The financial statements have been prepared to comply with current statutory requirements (being the Companies Act 2006, the Charities Act 2011, the Charities and Trustee Investment (Scotland) Act 2005 and the Charities Accounts (Scotland) Regulations 2006), under the historical cost convention, except for investments at market value, and in accordance with United Kingdom generally Accepted Accounting Practice. The recommendations in Accounting and Reporting by Charities: Statement of Recommended Practice (revised 2005) issued by the Charity Commission in March 2005 have been followed. The accounting policies have been applied consistently in prior years.

Basis Of Consolidation

The consolidated statement of financial activities and the balance sheet consolidate the financial statements of Anthony Nolan and its subsidiary undertaking, Anthony Nolan Trading Limited.

going Concern

The trustees have reviewed the group’s and the parent charity’s forecasts and projections covering a period that exceeds 12 months from the date of signing these financial statements, and based on the level of existing cash and estimated levels of income and expenditure, the trustees are satisfied that the charity has adequate resources to continue in operation for the foreseeable future. Accordingly, the going concern basis has been used in preparing these financial statements.

Incoming Resources

All incoming resources are included in the Statement of Financial Activities when the charity is entitled to the income, and the amount can be quantified with reasonable accuracy. Donations are normally brought into account when received, and are stated gross of any attributable tax recoverable. government and institutional grants are accounted for on a receivable basis. Donations and grants given for specific purposes are treated as restricted income.

Income from legacies is included in incoming resources on an accruals basis when, for a specific bequest, the three criteria of entitlement, certainty, and measurement can be satisfied and supported by third party confirmation. The charity does not account for legacies subject to a life interest held by another party until the life interest has expired.

Income in respect of payments for bone marrow transplants and other similar services derives from the amounts charged in respect of the search for matching tissue types and the arrangement of the bone marrow transplants, and is accounted for when receivable as incoming resources from charitable activities.

Income from fundraising events, and the associated costs, are included in incoming resources and resources expended following completion of the event. Income received and costs incurred prior to the date of an event are treated as deferred income and prepayments respectively.

All other income, including investment income, is accounted for on a receivable basis as and when earned.

3837

‘I’m not ever going to stop swimming; just because you’ve had a transplant doesn’t mean you can’t go out and do amazing things. And I can prove it.’

Beth Morris

gifts In Kind

The value of gifts in kind is recognised as income and as a cost where the value exceeds £1,000 on an individual basis and the value can be assessed with reasonable accuracy. The income is recognised in the SOFA when the gift is sold, which usually takes place at charitable events.

Resources Expended

All expenditure is accounted for on an accruals basis inclusive of any irrecoverable Value Added Tax, and is allocated as direct costs in the Statement of Financial Activities where the costs can be identified as being directly related to generating funds, to a charitable activity, or to governance matters. Where costs cannot be directly attributed, they are allocated to categories on a basis consistent with the budgeted use of the resources concerned and in proportions based upon a suitable ratio applicable to the nature of the cost involved.

governance Costs

governance costs consist of an estimate of time spent by senior executives in dealing with governance tasks and any direct costs associated with these tasks, including audit costs and trustee expenses. Compliance with the requirements of the Human Tissue Authority is included in governance.

Foreign Currencies

Transactions denominated in foreign currencies are recorded using the rate of exchange ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated using the rate of exchange ruling at the balance sheet date. All exchange gains or losses are included in the statement of financial activities in the period to which they relate.

Research And Development Expenditure

Expenditure on research and development is written off to the Statement of Financial Activities in the period in which it is incurred.

Tangible Fixed Assets

All tangible assets purchased costing more than £1,000 that have a useful economic life that exceeds one year are capitalised and classified as fixed assets, the exception being computer equipment, which is all capitalised, even if the cost is lower than £1,000. Tangible fixed assets are stated at historical cost less depreciation.

Depreciation is provided on all tangible fixed assets at rates calculated to write each asset down to its estimated residual value over its expected useful life, as follows:

• Leasehold buildings over the life of the lease

• Leasehold improvements

• Fixtures & fittings over 3 to 5 years

• Office equipment over 3 to 5 years

• Laboratory equipment over 3 to 5 years

Investments

Long term investments are classified as fixed assets, which are stated at market value in the Balance Sheet. Provision is made for any impairment in the value of fixed asset investments.

4039

‘The biggest thing I missed during my transplant was other people. I was used to having a lot of friends and colleagues around me, the usual banter you get when you work for the police. To come back, to have them around me, to have challenges: the old grey cells between my ears are working again. It’s great to be back.’

Rik Basra

Stocks

Stocks are valued at the lower of cost and net realisable value. Net realisable value is based upon estimated selling price less further costs expected to be incurred to disposal. Provision is made for obsolete and slow-moving items.

Leased Assets And Obligations

Where assets are financed by leasing agreements that give rights approximating to ownership (“finance leases”), the assets are treated as if they had been purchased outright. The amount capitalised is the present value of the minimum lease payments payable during the lease term. The corresponding leasing commitments are shown as obligations to the lessor.

Lease payments are treated as consisting of capital and interest elements, and the interest is charged to the statement of financial activities in proportion to the remaining balance outstanding.

All other leases are ‘operating leases’ and the annual rentals are charged to the Statement of Financial Activities on a straight line basis over the lease term.

Taxation

The company is a registered charity and as such its income and gains falling within Sections 471 to 489 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable gains Act 1992 are exempt from Corporation tax to the extent that they are applied to its charitable activities.

Pension Contributions

The group and the charity make contributions into defined contribution pension schemes on behalf of certain employees. The assets of the schemes are held separately from those of the group and the charity in independently administered funds. The amount charged to the Statement of Financial Activities in respect of pension costs is the total contributions payable for the year.

Fund Accounting

The general fund comprises the accumulated surpluses of unrestricted incoming resources over resources expended, which are available for use in furtherance of the general objectives of the charity. The investment revaluation reserve reflects gains or losses of the revaluation of the quoted investments.

Restricted funds are funds subject to specific conditions imposed by donors. The purpose and use of the restricted funds are set out in the notes to the accounts. Amounts unspent at the period end are carried forward in the balance sheet. Where the specific conditions of the donation are met so the funds are no longer restricted in purpose or use, unspent amounts are transferred to the general fund.

Designated funds are determined at the discretion of the board of trustees with regard to the resources needed for achieving the charity’s medium-term objectives.

Provisions

Provision is made by the group and the charity for liabilities and charges arising from legal or constructive obligations that exist at the balance sheet date on the basis of the estimated cost to settle the present obligation or transfer it to a third party at that date. Consideration is given to the timing of the cash flows and to future events and uncertainties which may affect the amount required to settle the obligations.

4241

Notes to the financial statements

The charity owns 100% of the issued share capital of Anthony Nolan Trading Limited (“ANTL”), a company registered in England. The charity acquired all of the 100 ordinary shares of £1 each that were issued in ANTL at par upon incorporation. These shares are carried in the balance sheet at their original cost of £100, which the trustees believe approximately equates to their market value.

The principal activity of ANTL is to carry on the trading operations of the group with a view to raising funds on behalf of the parent charity, which is achieved through the sale of merchandise, advertising, the organisation of fundraising events, and by exploiting intellectual property and other similar rights held by the parent charity. Annual financial statements for this subsidiary company are filed with the Registrar of Companies for England and Wales, and are publicly available.

201412 months

£’000

201318 months

£’000

A summary of the trading results of the subsidiary is set out below:

INCOME

Turnover 510 766

Investment income 2 3

512 769

EXPENDITURE

Cost of sales 245 453

Other operating expenses 144 131

Transfer under gift Aid to Anthony Nolan 123 128

512 712

RESULT FOR THE YEAR - 57

A summary of the balance sheet of the subsidiary is set out below:

CURRENT ASSETS

Debtors 315 133

Cash at bank & in hand 108 151

423 284

LIABILITIES

Creditors: Amounts falling due within one year 362 223

NET CURRENT ASSETS 61 61

TOTAL ASSETS LESS CURRENT LIABILITIES & NET ASSETS 61 61

CAPITAL AND RESERVES

Called up share capital - -

Profit & loss account 61 61

SHAREHOLDERS’ FUNDS 61 61


2: tRAdInG opeRAtIons & InVestMents

For the year ended 31 March 2014

Unrestricted Funds 12 months

£’000


£’000

Total 2014 12 months

£’000

Total 2013 18 months

£’000

Group and Charity

Donations from trusts and other similar institutions - 938 938 1,179

Corporate donations 21 302 323 1,284

Donations from individuals 5,994 48 6,042 5,487

Legacies 445 - 445 1,126

gifts in kind 115 - 115 199

6,575 1,288 7,863 9,275


1: VoluntARY IncoMe

Notes to the financial statementsFor the year ended 31 March 2014

4443


4: donoR pRoVIsIon IncoMe

Unrestricted Funds12 months

£’000

Restricted Funds12 months

£’000

Total 201412 months

£’000

Total 201318 months

£’000

Group & Charity

Fees receivable for the provision of donors 33,955 - 33,955 43,832

Support income in relation to donor processing 1,678 - 1,678 3,174

35,633 - 35,633 47,006

5: ReseARcH IncoMe

6: otHeR IncoMInG ResouRces


£’000


£’000

Total 201412 months

£’000

Total 201318 months

£’000

group

Other income 48 - 48 431

48 - 48 431

Charity

Anthony Nolan Trading Ltd: management charge 64 - 64 71

Other income 48 - 48 431

112 - 112 502


£’000


£’000

Total 201412 months

£’000

Total 201318 months

£’000

Group & Charity

grant income receivable 73 458 531 428



3: InVestMent IncoMe


£’000


£’000

Total 201412 months

£’000

Total 201318 months

£’000

Group

Rent receivable under operating leases 75 - 75 112

Bank interest receivable on short term cash deposits 4 - 4 17

Royalty income receivable 8 - 8 14

Return on investments 16 - 16 5

103 - 103 148

Charity

Rent receivable under operating leases 75 - 75 112

Bank interest receivable on short term cash deposits 4 - 4 17

Royalty income receivable 7 - 7 12

Return on investments 16 - 16 5

Anthony Nolan Trading Ltd: gift Aid payment 123 - 123 128

225 - 225 274


4645


8: suppoRt costs BY ActIVItY

Basis Of The Allocation Of Expenditure

Where appropriate, expenditure, including depreciation, is allocated directly to the activity to which that expenditure relates.

Expenditure which does not relate directly to an activity but are incurred to enable activities to occur are classified as support costs.

Support costs are apportioned to the activities they support on a reasonable, justifiable and consistent basis. The bases are:

• Finance and management costs relating to governance are estimated based on the time and resources incurred on governance activities.

• Other finance costs are apportioned in proportion to total direct expenditure incurred per activity.

• All other support costs are apportioned in accordance with the full time equivalent number of staff directly employed in that activity.

Support Costs

Group and Charity Facilities Finance and management Human Resources IT Total

2013/2014 12 MONTHS £’000 £’000 £’000 £’000 £’000

Costs of generating fundsFundraising costs 101 349 78 176 704

Charitable activitiesDonor Provision 511 2,092 393 893 3,889

Education and awareness 85 114 65 148 412

Research 68 88 53 119 328

Governance costs - 267 - - 267

Total support costs 765 2,910 589 1,336 5,600

2011/2013 18 MONTHS £'000 £'000 £'000 £'000 £'000

Costs of generating fundsFundraising costs 134 304 112 185 735

Charitable activitiesDonor Provision 684 2,368 571 952 4,575

Education and awareness 102 114 85 141 442

Research 96 74 80 134 384

Governance costs - 325 - - 325

Total support costs 1,016 3,185 848 1,412 6,461



7: totAl ResouRces eXpended

Activities undertaken directly Support costs (note 8) Total Costs

Group Staff costs Other costs Total Staff costs Other costs Total

2013/2014 12 MONTHS £’000 £’000 £’000 £’000 £’000 £’000 £’000

Costs Of Generating Funds

Fundraising costs 1,237 3,811 5,048 283 421 704 5,752

Commercial trading operations: cost of goods sold and other costs - 324 324 - - - 324


Donor Provision 5,391 24,721 30,112 1,509 2,380 3,889 34,001

Education and awareness 1,015 652 1,667 194 218 412 2,079

Research 1,120 682 1,802 156 172 328 2,130

Governance costs - - - 140 127 267 267

Total resources expended 8,763 30,190 38,953 2,282 3,318 5,600 44,553

2011/2013 18 MONTHS £'000 £'000 £'000 £'000 £'000 £'000 £'000



Commercial trading operations: cost of goods sold and other costs - 513 513 - - - 513


Donor Provision 6,711 31,743 38,454 1,957 2,618 4,575 43,029


Research 1,487 738 2,225 190 194 384 2,609

Governance costs - 106 106 203 122 325 431


Activities undertaken directly Support costs (note 8) Total Costs

Charity Staff costs Other costs Total Staff costs Other costs Total

2013/2014 12 MONTHS £’000 £’000 £’000 £’000 £’000 £’000 £’000



Donor Provision 5,391 24,721 30,112 1,509 2,380 3,889 34,001


Research 1,120 682 1,802 156 172 328 2,130

Governance costs - - - 140 127 267 267


2011/2013 18 MONTHS £'000 £'000 £'000 £'000 £'000 £'000 £'000




Donor Provision 6,711 31,743 38,454 1,957 2,618 4,575 43,029


Research 1,487 738 2,225 190 194 384 2,609

Governance costs - 106 106 203 122 325 431



4847


10: net MoVeMent In Funds

2014 12 months

£’000

2013 18 months

£’000

Net movement in funds is stated after charging

Depreciation and amounts written off tangible fixed assets: 633 673

Charge for the year - owned assets 590 609

Charge for the year - assets under finance lease 43 64

Research and development expenditure 1,802 2,225

Operating lease rentals:

Land and buildings 291 409

Plant and machinery 4 29

Auditor’s remuneration:

Statutory Audit fees payable to

Baker Tilly UK Audit LLP (Charity £30k (2013: £31k)) 39 31

Tax Services payable to

Baker Tilly Tax & Accounting Ltd:

Compliance 4 1

Advisory 3 -

Other Services 13 49

The trustees neither received nor waived any emoluments for their services to the group or the charity, and were not reimbursed for any expenses incurred on behalf of the group or the charity during the current year or previous years.

The group and the charity have an insurance policy that provides professional indemnity insurance cover for the trustees. The cost of this insurance for the year was £1k (2013: £2k).

During the year to 31 March 2014, the group made net foreign exchange gains of £46k. In 2011/13 net exchange gains were £431k .

Forward exchange contracts are used to manage the charity’s exposure to currency exchange risk in respect of the settlement of supplier payments in US$ and Euros. As at the balance sheet date the fair value of outstanding transactions totals £8,506 (2013:nil).



9: stAFF costs

2014 (12 months) 2013 (18 months)

No. No.

The average monthly number of persons employed by the group during the year (excluding trustees) was:

Charitable activities:

Donor provision 197 157

Education and awareness 27 22

Research 21 21

Fundraising 36 30

governance 3 3

284 233

£’000 £’000

Staff costs for the above:

Wages and salaries 8,880 10,747

Social security costs 892 1,083

Pension costs 255 369

10,027 12,199

Staff costs are allocated in the group’s financial statements as follows:

Donor provision 6,903 8,668

Education and awareness 1,210 1,335

Research 1,276 1,677

Fundraising 1,517 1,802

governance 140 203

11,046 13,685

The number of employees whose emoluments for the period fell within the following ranges was: 2014 No

2013* No

£60,001 to £70,000 1 2

£70,001 to £80,000 3 3

£80,001 to £90,000 2 2

£90,001 to £100,000 - 2

£100,001 to £110,000 1 1

£120,001 to £130,000 1 1

* Annualised equivalent.

Included in the allocated staff costs (note 7), in addition to payroll costs are the costs of funding academic positions of £156k (2013: £191k), staff benefit costs of £86k (2013: £101k), and agency staff and other similar costs of £748k (2013: £1,133k).

The group made contributions to money purchase pension schemes on behalf of all employees whose emoluments exceeded £60,000, and the total contributions payable during the year amounted to £43k (18 months 2013: £83k).

During 2013/2014 the charity continued development work on upgrading the donor database system CORAL. £238k worth of software developers’ staff costs was capitalised (2013: £324k), including £212k wages and salaries (2013: £288k), £22k of social security costs (2013: £33k) and £4k pension costs (2013: £3k).


5049


12: InVestMents

Group

Listed investments £’000

Valuation

at 1 April 2013 6

Write offs/Disposals (6)

At 31 March 2014 -

Charity

Listed investments £’000

Valuation

at 1 April 2013 6

Write offs/Disposals (6)

At 31 March 2014 -

Investments in subsidiaries

Investments in subsidiaries at cost

As at 1 April 2013 and 31 March 2014 -

group 2014 group 2013 Charity 2014 Charity 2013

£’000 £’000 £’000 £’000

Raw materials and consumables 485 479 485 479

13: stocKs

The charity owns 100,000 shares in Eurovestech Plc. These shares were donated as part of the corporate social responsibility of Eurovestech. The shares were de-listed on 30/9/12 and their value was written off on 31/3/14.



11: tAnGIBle Assets

Leasehold buildings Leasehold improvements

fixtures & fittings

Officeequipment

Laboratoryequipment

TOTAL

Long term Short term

£’000 £’000 £’000 £’000 £’000 £’000

Group & Charity

Cost:

01 April 2013 1,842 137 709 1,935 2,184 6,807

Additions - - 144 852 386 1,382

31 March 2014 1,842 137 853 2,787 2,570 8,189

Depreciation:

01 April 2013 503 40 589 1,017 1,482 3,631

Charge for the year 16 6 74 256 281 633

31 March 2014 519 46 663 1,273 1,763 4,264

Net book value:

31 March 2014 1,323 91 190 1,514 807 3,925

31 March 2013 1,339 97 120 918 702 3,176

Certain leasehold buildings are used, when surplus to the group’s and the charity’s requirements, to generate rental income under operating leases.

The net book value of assets held under finance leases included in the above total at 31 March 2014 was £71k (2013: £114k). Depreciation amounting to £43k was charged in the period relating to assets held under finance leases (2011/13: £64k).”


5251


16: MoVeMents In deFeRRed IncoMe


£’000 £’000 £’000 £’000

Deferred income at beginning of the year 395 80 244 63

Income recognised in the year (395) (899) (244) (881)

Income deferred in the current year 1,188 1,214 851 1,062

Deferred income at the year end 1,188 395 851 244

group 2014£’000

group 2013£’000

group 2014£’000

group 2013£’000

Finance lease commitments

Repayable within 1-2 years 28 43 28 43

Repayable within 2-5 years - 28 - 28

28 71 28 71

17: cRedItoRs: AMount FAllInG due AFteR one YeAR



14: deBtoRs


£’000 £’000 £’000 £’000

Amounts falling due within one year:

Trade debtors 5,550 2,751 5,507 2,692

gift Aid receivable from group undertakings - - 123 128

Other debtors 75 40 75 38

Prepayments and accrued income 4,483 5,711 4,417 5,638

10,108 8,502 10,122 8,496


£’000 £’000 £’000 £’000

Trade creditors 5,107 5,444 5,097 5,415

Amounts due to group undertakings - - 328 85

Other creditors 39 40 39 40

Other taxation and social security costs 416 432 410 431

Accruals and deferred income 4,455 2,601 4,109 2,449

Finance lease payable 43 43 43 43

10,060 8,560 10,026 8,463

15: cRedItoRs: AMounts FAllInG due WItHIn one YeAR


5453


19: tHe Funds oF tHe GRoup & tHe cHARItY

Balance at 01-Apr 2013

£’000

Incoming resources

£’000

Outgoingresources

£’000

gross transfersbetween Funds

£’000

Other gainsand losses

£’000

Balance at31-Mar 2014

£’000

GroupRestricted income fundsVoluntary incomeDonor Campaign and Processing Fund 16 294 (310) - - -

Donor Provision Fund - 163 (163) - - -

Cord Blood Collection Centres Fund 73 127 (207) - - (7)

Scientific Research Fund - 68 (68) - - -

Laboratory equipment Fund 135 152 (23) (234) - 30

Cell Therapy Fund - 53 (53) - - -

Regional growth Project Fund - 431 (294) (137) - -

224 1,288 (1,118) (371) - 23

Scientific Research Funds 108 458 (299) 73 - 340

332 1,746 (1,417) (298) - 363

Unrestricted income funds

Designated funds

Donor recruitment and processing fund 1,450 - - (1,450) - -

Clinicial trials coordination 50 - - (50) - -

Third generation Sequencing (TgS) Fund - - - 1,500 - 1,500

1,500 - - - - 1,500

general Fund 6,770 42,942 (43,136) 298 (16) 6,858

Investment revaluation reserve (10) - - - 10 -

8,592 44,688 (44,553) - (6) 8,721

CharityRestricted income fundsVoluntary incomeDonor Campaign and Processing Fund 16 294 (310) - - -

Donor Provision Fund - 163 (163) - - -

Cord Blood Collection Centres Fund 73 127 (207) - - (7)

Scientific Research funds - 68 (68) - - -

Laboratory equipment Fund 135 152 (23) (234) - 30

Cell Therapy Fund - 53 (53) - - -

Regional growth Project Fund - 431 (294) (137) - -

224 1,288 (1,118) (371) - 23

Scientific Research Funds 108 458 (299) 73 - 340

332 1,746 (1,417) (298) - 363

Unrestricted income fundsDesignated fundsDonor recruitment and processing fund 1,450 - - (1,450) - -

Clinicial trials coordination 50 - - (50) - -

Third generation Sequencing (TgS) Fund - - - 1,500 - 1,500

1,500 - - - - 1,500

general Fund 6,710 42,618 (42,812) 298 (16) 6,798

Investment revaluation reserve (10) - - - 10 -

8,532 44,364 (44,229) - (6) 8,661



18: pRoVIsIons FoR lIABIlItIes & cHARGes

group 2014 £’000

group 2013 £’000

group 2014 £’000

group 2013 £’000

Provision for dilapidations 316 316 316 316

Notes to the financial statements

A provision for dilapidations is being carried in the balance sheets of the group and the charity in respect of the estimated costs of unavoidable reinstatement and refurbishment works relating to certain leasehold properties that are currently occupied by the charity for its own use. This provision was created in 2004, added to in 2009 upon renewal of the lease, increased in 2011/13 from £296k to £316k, and is now expected to be utilised at the earliest in the financial year 2014/2015.

For the year ended 31 March 2014

5655


20: AnAlYsIs oF net Assets BetWeen Fund

Fixed assets

£’000

Net current assets

£’000

Creditors over 1 year & provisions for

liabilities & charges £’000

Total

£’000

Group

Restricted income funds - 363 - 363

Unrestricted income funds: general Fund 3,925 4,777 (344) 8,358

NET ASSETS 3,925 5,140 (344) 8,721

Charity

Restricted income funds - 363 - 363

Unrestricted income funds: general Funds 3,925 4,717 (344) 8,298

NET ASSETS 3,925 5,080 (344) 8,661

21: ReconcIlIAtIon oF net cAsH FloW to MoVeMents In Funds

group 2014 £’000

group 2013 £’000

Charity 2014 £’000

Charity 2013 £’000

Decrease in cash in the year (726) 2,350 (683) 2,695

Cash outflow to decrease debt lease finance (43) (43) (43) (43)

CHANGE IN NET FUNDS (769) 2,307 (726) 2,652

Net funds at 1 April 2013 5,376 3,069 5,225 2,573

NET FUNDS AT 31 MARCH 2014 4,607 5,376 4,499 5,225


Donor Campaign And Processing Fund: in 2013/2014 the charity received various grants to recruit and type to high resolution male donors aged between 16 and 30 years. The biggest contributor was ITV Studios with the donation of £249k.

Donor Provision fund: during the year various grants were received for the purposes of recruiting donors for the charity’s registry.

As part of its commitment to increase the use of cord blood, Anthony Nolan has plans to open cord blood collection centres at a number of hospitals. Donations received to support this expansion programme are credited to the Cord Blood Collection Centres Fund. Expenditure incurred in opening the centres is charged to the Fund. The deficit of £7k represents the expenditure incurred in 2013/14 which will be covered by donations in 2014/15.

The Scientific Research Fund was set up in 2008/2009 to recognise income received annually in the form of a number of different grants awarded for specific research projects in immunogenetics and related fields. The cost of undertaking these research projects is allocated to the fund, with unspent monies being carried forward into 2014/2015.

Donations and grants received to fund the purchase of specific items of laboratory equipment for either research or histocompatability laboratories are credited to the Laboratory equipment Fund. When the specified asset is purchased and there is no ongoing restriction over its use, the value of the asset is transferred to general Fund. £234k was transferred from Laboratory Equipment Fund to general Fund in 2013/14. The depreciation of the asset is charged to the general Fund over the life of the asset.

The Cell Therapy Fund was set up to reflect the grants and donations for the purposes of processing the collected umbilical cords and the associated research.

In 2013/14 Anthony Nolan was awarded with a grant from the Regional growth Fund. The aim of the Regional growth Project Fund was to set up three additional cord collection centres – two in Nottingham and one in Manchester, as well as to enhance the facilities for cord processing in the Anthony Nolan Cell Therapy Centre. The project will run into 2014/15.

During 2011/13 two designated funds were created: Donor Recruitment and Processing and Clinical Trial Coordination. During 2013/2014 these funds were re-designated by the Board of Trustees for the Third generation Sequencing (“TgS”) fund.

The investment revaluation reserve represents the difference between the historic cost of investments and their revalued amount at the balance sheet date.


5857


24: pensIon coMMItMents

25: RelAted pARtY tRAnsActIons

The group and the charity make contributions into defined contribution pension schemes on behalf of certain employees. The assets of the schemes are held separately from those of the group and the charity in independently administered funds. The amount charged to the Statement of Financial Activities in respect of pension costs (as shown in note 9) is the total contributions payable for the period.

The charity has taken advantage of the exemptions provided by Financial Reporting Standard No.8: Related Party Disclosures, and has not disclosed transactions with fellow group undertakings on the basis that 100% of the voting rights are controlled within the group, and that group accounts are publicly available. There are no other related party transactions to be disclosed.

26: cApItAl coMMItMents

CAPITAL COMMITMENTSgroup 2014

£’000group 2013

£’000Charity 2014

£’000Charity 2013

£’000

Capital commitments - contracted for, but not provided 1,269 47 1,269 47


1 Apr 2013 £’000

Cash Flows £’000

Non-cash changes £’000

31 March 2014 £’000

Group

Cash in hand, at bank 5,376 (769) - 4,607

Finance leases 207 - 28 235

NET FUNDS 5,583 (769) 28 4,842

Charity

Cash in hand, at bank 5,225 (726) - 4,499

Finance leases 207 - 28 235

NET FUNDS 5,432 (726) 28 4,734

23: coMMItMents undeR opeRAtInG leAses

group 2014 £’000

group 2013 £’000

Charity 2014 £’000

Charity 2013 £’000

At 31 March 2014, the group and the charity have annual commitments under non-cancellable operating leases as follows:

LAND AND BUILDINgS

Expiring in less than one year 31 - 31 -

Expiring between two and five years 6 6 6 6

Expiring after five years 181 196 181 196

PLANT AND MACHINERY

Expiring between one and two years 3 - 3 -

Expiring between two and five years 4 7 4 7

225 209 225 209


22: AnAlYsIs oF cHAnGes In net Funds


6059

Thank You

We know we can only do what we do because of so many fantastic individuals and organisations. So here’s to all you cash givers, will rememberers, pedal pushers, sky divers, marathon beaters, time sparers, trek conquerors, and all those fantastic fundraisers, charitable companies, generous groups and terrific trusts – without your help, we simply couldn’t save lives.

The following organisations and individuals are amongst those who provided financial support during the year:

CALM Trust

Eveson Charitable Trust

Haramead Trust

Hugh Fraser Foundation

Jack Petchey Foundation

Liz and Terry Bramall Foundation

Patrick Rowland Foundation

Robertson Trust

Sir John Fisher

Smile for Life

Sue Harris Bone Marrow Trust

Tracy Sollis Leukaemia Trust

UK Stem Cell Foundation

Westfield Health Charitable Trust

William Frederick Haines Foundation

Wolfson Foundation

Baker Tilly

Furniture Village

Metro

Deloitte

Mail Newspapers

Virgin Money

ACS Business Supplies

Barrow for Marrow

All those that continue to fundraise in memory of Helen Clark

All those that continue to fundraise in memory of Alex Mcgrory

All those that continue to fundraise in memory of Chaz Blinstrub

All those that continue to fundraise in memory of Mike Neal

All those that have supported the Catherine Melrose Appeal

All those that have supported the Ailsa Croll Appeal

The Midlife Cyclists – Ben, Alasdhair and Andy

gary Marshall and The Covent garden Tenants Association

All those that have supported the Ayesha Siddiqui Appeal

Everyone that is forever Rallying for Ronnie

Sophie and Andy Baker

Mr Nitin Changela

The National Society of Allied and Independent Funeral Directors

All of our Friends of Anthony Nolan groups and Tea Bars

All of our Marrow groups

The Daisy Ball Commitee

61

Documents

2013 Anthony 2014 nolAn · was created by Anthony Nolan’s mother, Shirley, in the hope of finding a cure for the life-threatening blood disorder her son had been born with. In 2014